|

Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

RECRUITINGSponsored by Chongqing University Cancer Hospital
Actively Recruiting
SponsorChongqing University Cancer Hospital
Started2022-01-01
Est. completion2024-04-30
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06317610

Summary

The present study aims to collect early bright field image of patient-derived organoids with ovarian cancer. By leveraging artificial intelligence, this study will seek to construct and refine algorithms that able to predict growth of ovarian cancer organoids.

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Patients must have histologically confirmed diagnosis of epithelial ovarian cancer
* Patients received biopsy or puncture to obtain tumor tissues or malignant effusion
* Patients voluntarily participated in the study and signed informed consent.

Exclusion Criteria:

* Non-epithelial ovarian cancer
* No sufficient amount of tumor tissues or malignant effusion for organoids establishment.

Conditions2

CancerOvarian Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.